feed,title,long_url,short_url
Benzinga,Corcept Stops Phase 2 NASH Study With Miricorilant Due To Elevated Liver Enzymes In Patients,https://benzinga.com/general/biotech/21/05/21008750/corcept-stops-phase-2-nash-study-with-miricorilant-due-to-elevated-liver-enzymes-in-patients,https://j.mp/3usdZ4T
Benzinga,32 Stocks Moving in Friday's Pre-Market Session,https://benzinga.com/news/21/05/21009173/32-stocks-moving-in-fridays-pre-market-session,https://j.mp/33pDFD2
